
Drug Development and Sports: The 10-Run Rule and Futility
Episode 59
In this episode of "In the Interim…", Dr. Scott Berry and Dr. Nick Berry investigate how futility in clinical trials and stopping rules in sports illuminate very similar decision problems, albeit with very different consequences. Drawing from baseball’s 10-run rule, tournament cuts in golf, the discussion confronts traditional and Bayesian strategies for interim decisions. The episode explains why simulation, not historical trial review, provides the empirical backbone for futility boundaries in clinical trials, and details the mechanics and consequences of aggressive stopping criteria. Using the Biogen aducanumab Alzheimer’s trials, the conversation exposes how a futility rule based on 20% predictive probability halted trials even when meaningful probability of success remained. Scott and Nick address the influence of ethical considerations, cost, regulatory priorities, and statistical rigor, and contrast Bayesian predictive probability’s strengths over conditional power.
Publisher
In the Interim...
Link
share.transistor.fm/s/2bbc6faf
Published
April 27, 2026
Duration
52 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Berry
In the Interim...
@intheinterim
#drugdevelopment #runrule #futility #mathematics #medicine
